Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Clin Cancer Res ; 12(6): 1906-12, 2006 Mar 15.
Article in English | MEDLINE | ID: mdl-16551876

ABSTRACT

PURPOSE: Convective transport of macromolecules from the peritoneal cavity into tumor is determined by its hydraulic permeability and the pressure gradient. Previous studies showed that establishing a pressure gradient into the tumor failed to result in significant penetration. This study addresses the hypothesis that the extracellular matrix is the major resistance to the penetration of an i.p. injected antibody. EXPERIMENTAL DESIGN: Human ovarian tumors (SKOV-3 and OVCAR-3) were established in the abdominal wall of athymic rats. After anesthesia, the tumor serosal surface was treated for 2 hours with Krebs solution (control), collagenase (37.5 unit/mL), or hyaluronidase (10 unit/mL) followed by 3 hours of convective delivery of radiolabeled IgG. Transport of antibody into the tumor was measured with quantitative autoradiography along with the tumor interstitial pressure, concentration of collagen and hyaluronic acid, and IgG volume of distribution. RESULTS: Antibody was excluded from 42% to 53% of tumor extracellular volume. Exposure of tumors to hyaluronidase did not enhance IgG transport despite removal of 90% of the hyaluronan from the exposed tumor. In contrast, collagenase reduced collagen content, lowered tumor interstitial pressure, and markedly enhanced antibody penetration. CONCLUSIONS: Reduction of collagen, but not hyaluronan, in the matrix of ovarian xenografts enhanced the transport of i.p. injected antibody. Although high interstitial pressure is a deterrent to convective transport of macromolecules into the tumor parenchyma, the structure of the interstitial matrix provides an inherent resistance, which must be overcome before effective delivery of an antibody.


Subject(s)
Collagen/metabolism , Immunoglobulin G/therapeutic use , Immunotherapy/methods , Ovarian Neoplasms/therapy , Animals , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/pharmacokinetics , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/pharmacokinetics , Antineoplastic Agents/therapeutic use , Biological Transport/drug effects , Cell Line, Tumor , Collagenases/administration & dosage , Extracellular Matrix/metabolism , Female , Humans , Hyaluronoglucosaminidase/administration & dosage , Immunoglobulin G/administration & dosage , Immunoglobulin G/metabolism , Injections, Intraperitoneal , Neoplasm Metastasis , Ovarian Neoplasms/metabolism , Ovarian Neoplasms/pathology , Rats , Rats, Nude , Trastuzumab , Xenograft Model Antitumor Assays
2.
Clin Cancer Res ; 11(8): 3117-25, 2005 Apr 15.
Article in English | MEDLINE | ID: mdl-15837768

ABSTRACT

PURPOSE: Despite evidence that regional chemotherapy improves the treatment of metastatic peritoneal ovarian carcinoma, monoclonal antibodies have not shown significant success in i.p. delivery. The present study was designed to address the hypothesis that convective penetration of macromolecular antineoplastic agents depends on a positive pressure difference between the i.p. therapeutic solution and the tumor. EXPERIMENTAL DESIGN: Nude rats with human ovarian xenografts implanted in the abdominal wall were used in experiments to facilitate in vivo measurement of tumor pressure and the treatment of the tumor with i.p. solutions at high pressures. Penetration of (125)I-labeled trastuzumab was measured with quantitative autoradiography. RESULTS: Tumor pressure profiles showed peak pressures of 32 mm Hg with mean pressures (+/- SD, mm Hg) in 12 SKOV3 tumors of 9.7 +/- 8.3 and in 15 OVCAR3 tumors of 12.5 +/- 7.0. I.p. therapeutic dwells at 6 to 8 mm Hg (maximum feasible pressure) showed significantly less penetration of trastuzumab than in adjacent normal muscle. To establish a driving force for convection into the tumor, various maneuvers were attempted to reduce tumor pressure, including treatment with taxanes or prostaglandin E(1), elimination of tumor circulation, and removal of the tumor capsule. Tumor decapsulation decreased the pressure to zero but did not enhance the penetration of antibody. Binding to specific trastuzumab receptors on each tumor was shown to be not a significant barrier to antibody penetration. CONCLUSIONS: The results only partially support our hypothesis and imply that the microenvironment of the tumor is in itself a major barrier to delivery of charged macromolecules.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Ovarian Neoplasms/drug therapy , Animals , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/pharmacokinetics , Antibodies, Monoclonal, Humanized , Blood Circulation/drug effects , Cell Line, Tumor , Female , Humans , Injections, Intraperitoneal , Iodine Radioisotopes , Neoplasm Metastasis , Ovarian Neoplasms/pathology , Ovarian Neoplasms/physiopathology , Peritoneum/metabolism , Pressure , Rats , Rats, Nude , Trastuzumab , Xenograft Model Antitumor Assays/methods
3.
Perit Dial Int ; 26(2): 249-58, 2006.
Article in English | MEDLINE | ID: mdl-16623433

ABSTRACT

OBJECTIVES: Acute infection in an animal model of chronic peritoneal dialysis (PD) induces structural changes in the peritoneum and altersfunctional characteristics of transport. These changes may compromise observations of the chronic effects of dialysis solutions. To test the hypothesis that antibiotics would prevent acute infection without affecting transport and structural properties, we characterized the frequency of infection in our rat model of PD and examined whether the inclusion of antibiotics in the dialysis solution altered the transport and structural properties of the peritoneum. DESIGN: Female Sprague-Dawley rats were aseptically injected daily under gas anesthesia with 30 - 40 mL of a sterile solution for 2 months via a peritoneal catheter tunneled to a subcutaneous port. Solutions used were Krebs-Ringer bicarbonate (KRB) alone, KRB with antibiotics (cefazolin 200 mg/L and gentamicin 2 mg/L), KRB with 4% glucose, and KRB with both glucose and antibiotics. After 2 months, osmotic filtration andsolute transport were assessed in each animal and peritoneal fluid was collected for bacterial culture. Angiogenesis was evaluated by quantitative image analysis of tissue sections stained with CD31. Tissue content of collagen, hyaluronic acid, and sulfated glycosaminoglycan was determined. RESULTS: Technique survival (successful PD for 2 months) and infection rate were comparable among all treated groups. There were no differences between the groups in transport properties. Structural changes were comparable between groups, with or without antibiotics. CONCLUSIONS: Addition of antibiotics to the dialysis solution did not affect thetransport characteristics of the peritoneum or the pathologic reaction of the tissue to the PD solution.


Subject(s)
Antibiotic Prophylaxis , Bacterial Infections/prevention & control , Peritoneal Dialysis/adverse effects , Animals , Bacterial Infections/etiology , Disease Models, Animal , Female , Rats , Rats, Sprague-Dawley
4.
Am J Physiol Renal Physiol ; 291(5): F1096-103, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16684927

ABSTRACT

To address the hypothesis that functional changes in tissue transport can be related to structural alterations, we combined mathematical modeling with in vivo experimentation. The model concept includes interstitial diffusion and removal by a distributed microvasculature. Transport of solute and water across the peritoneum is measured via a plastic chamber affixed to the abdominal wall of anesthetized Sprague-Dawley rats. Solutions containing [(14)C]mannitol, with or without vasoactive compounds [control (C; n = 10), C + nitroprusside (NP; n = 10), C + norepinephrine (NE; n = 10)], were infused into the chamber, and the volume and tracer concentrations were determined over 60 min to calculate the mass transfer coefficient (MTC) and the water flux. At 60 min, FITC-dextran (500 kDa) was given to mark the perfused vasculature. After euthanasia, the tissue under the chamber was frozen, dried, sliced with a cryomicrotome, and examined with fluorescent microscopy and quantitative autoradiography. The microvessel density (x10(3)/cm(2): NE, 50 +/- 10; C, 180 +/- 7.0; NP, 225 +/- 15) resulted in marked differences (P < 0.05) in water flux (mul.min(-1).cm(-2): NE, 0.1 +/- 0.1; C, 1.6 +/- 0.4; NP, 1.0 +/- 0.2) and in mannitol MTC (x10(3) cm/min: NE, 0.9 +/- 0.3; C, 3.8 +/- 0.3; NP, 3.6 +/- 0.6). Concentration profiles and calculated capillary permeability and tissue diffusivity were significantly different among the groups. These results demonstrate a direct correlation of mass transfer, diffusion, capillary permeability, and water flux with peritoneal vascular density and validate a method by which mechanistic changes in transport may be measured.


Subject(s)
Biological Transport/physiology , Models, Biological , Peritoneum/metabolism , Animals , Biological Transport/drug effects , Capillary Permeability/drug effects , Capillary Permeability/physiology , Carbon Radioisotopes , Diffusion , Diuretics, Osmotic/pharmacokinetics , Female , Mannitol/pharmacokinetics , Nitroprusside/pharmacology , Norepinephrine/pharmacology , Rats , Rats, Sprague-Dawley , Solutions/metabolism , Vasoconstrictor Agents/pharmacology , Vasodilator Agents/pharmacology , Water/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL